Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001181431-13-043337

Director sold 12,500 shares at $12.41 ($155,125)

  • Director acquired 12,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

WHITFIELD ROY A · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2013-08-05 Exercise or conversion : show line 1 in the form +12,500 $11.41 $142,625 32,500 D
2013-08-05 Sale : show line 2 in the form −12,500 $12.41 $155,125 20,000 D
Open-market sales · 12,500 sh · avg $12.41 · $155,125

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2013-08-05 Exercise or conversion : show line 3 in the form Stock Option −12,500 $11.41 2013-09-03 12,500 0 D
Loading xslF345X03/rrd387477.xml…